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Abstract
Background: Biological pathways are central to many biomedical studies and are frequently discussed in the
literature. Several curated databases have been established to collate the knowledge of molecular processes
constituting pathways. Yet, there has been little focus on enabling systematic detection of pathway mentions in
the literature.
Results: We developed a tool, named PathNER (Pathway Named Entity Recognition), for the systematic
identification of pathway mentions in the literature. PathNER is based on soft dictionary matching and rules, with
the dictionary generated from public pathway databases. The rules utilise general pathway-specific keywords,
syntactic information and gene/protein mentions. Detection results from both components are merged. On a gold-
standard corpus, PathNER achieved an F1-score of 84%. To illustrate its potential, we applied PathNER on a
collection of articles related to Alzheimer’s disease to identify associated pathways, highlighting cases that can
complement an existing manually curated knowledgebase.
Conclusions: In contrast to existing text-mining efforts that target the automatic reconstruction of pathway details
from molecular interactions mentioned in the literature, PathNER focuses on identifying specific named pathway
mentions. These mentions can be used to support large-scale curation and pathway-related systems biology
applications, as demonstrated in the example of Alzheimer’s disease. PathNER is implemented in Java and made
freely available online at http://sourceforge.net/projects/pathner/.
Biological pathway mentions text mining, Alzheimer?’?s pathways, systems biology
Background
Systems biology places special emphasis on the large-
scale integration of various data and “scattered pieces of
knowledge” [1]. This is particularly challenging for the
knowledge coming from the literature, which is one of
the most important sources of information for biological
studies. Over 20 million citations have been included in
PubMed [2] and this number is growing. Various text
mining techniques have been explored, developed and
used to provide access to biological knowledge from
that massive amount of publications in a systematic and
automated way to support knowledge discovery and
hypothesis generation in particular in the context of sys-
tems biology [3].
Biological Named Entity Recognition (NER), specifi-
cally, is a key part of biomedical text mining as biologi-
cal entities are basic actors in biological systems and
processes. Promising and useful results have been
achieved in recognising genes [4], chemicals [5], anat-
omy parts [6], species [7], etc. Alongside with those
entities, biological pathways play an important role in
systems biology studies. Each pathway is formed by a
collection of entities (e.g. proteins) and interactions, and
carries some biological function. For many pathways,
specific names are gradually established and used within
the community in order to avoid repeated descriptions
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of molecular details for the convenience of communica-
tion. Yet, there has been little focus on enabling sys-
tematic detection of pathway mentions in the literature.
On the other hand, similarly to entities and molecular
interactions, biological pathways are extensively curated.
A number of databases have been built to store the
details of curated pathways, including KEGG [8], Path-
way Interaction Database (PID) [9], WikiPathways [10],
MetaCyc [11], Reactome [12] and integrative databases
like Pathway Commons [13] and ConsensusPathDB [14].
ConsensusPathDB in particular is one of the most com-
prehensive collections of pathways as it integrates more
than 4,000 pathways from twelve data sources (see
Table 1). Furthermore, the Pathway Ontology (PO) [15]
is built to organise various types of biological pathways
including classic metabolic, regulatory, signalling, drug
and disease pathways. It also offers altered pathways and
lists of pathway name synonyms.
Although the so-called “deep approach” to pathway
curation is likely to remain dominant in the near future
as automated methods for pathways reconstruction are
yet to match human curators [1], several text-mining
applications have been used to support automatically
(re)constructing pathways from molecular interactions
and metabolic reactions described in publications
[16-18] (see [19] for an overview). For example, Path-
Text [18] integrates pathway visualisation, text mining
and annotation tools, and supports navigation through
pathways where nodes and links are enriched by text
mining results. The objectives of those pathway recon-
struction systems are different from the focus of this
paper: while they are aiming for automated extraction of
molecular details to build pathways, we focus on the
recognition of mentions of known pathways in the lit-
erature. To achieve that, we developed PathNER, a NER
tool dedicated to the systematic identification of named
pathway mentions in the literature using text-mining
techniques. It aims to support both systems biology stu-
dies and pathway curation efforts. For example, the
identification of pathway mentions in the literature
makes it possible to answer questions of the type “what
pathways have been linked to a given disease?”. Further-
more, the analysis of pathway mentions could provide
valuable hints on pathways that should be prioritised
for curation. In addition, pathways that are frequently
reported as associated to the disease of interest could be
the focus of community efforts towards consensus
descriptions (see [20] for an example).
There are several systems that are closely related but
not dedicated to the task presented here. For example,
LitInspector [21] labels genes and general pathway key-
words in PubMed abstracts to improve their readability
and accelerate literature search. Its support for mining
signal transduction pathways is however limited to exact
matching of a proprietary list of names and keywords.
CoPub [22] is a general term search system that also
supports identification of pathway terms defined by a
thesaurus compiled from KEGG, HumanCyc and Reac-
tome. The search in CoPub is empowered by regular
expression matching with some limited expansion of
exact dictionary matching of its pathway thesaurus.
PathNER, on the other hand, uses soft dictionary match-
ing and flexible rules to identify potential pathway
mentions.
In the remainder of this paper, we first introduce Path-
NER and evaluate its performance on a gold-standard
corpus we developed. We then demonstrate the potential
of PathNER in a case study focused on pathways related
to Alzheimer’s disease.
Methods
We focus on named pathway mentions that are referred in
text by using a specific name (e.g. “MAPK signalling path-
way”, “Calcium signalling”). Such names often contain
general pathway-specific keywords ("pathway”, “signalling
pathway”, “cascade”, etc.) and mentions of associated
genes. However, many occurrences of general pathway
keywords are ambiguous (e.g., “the diagnostic pathway” is
not a biological pathway). Inversely, many pathway names
do not contain obvious pathway-related keywords (e.g.
“RNA degradation” [KEGG PATHWAY: hsa03018]).
Dictionary of pathway names
A dictionary of pathway names was compiled from the
Pathway Ontology [15] and ConsensusPathDB [14], focus-
ing on human biological pathway mentions only. We gen-
erated additional variants from entries that contained
acronyms or synonyms. The final dictionary contains
6,343 entries (see Additional file 1). Each entry is com-
posed of a pathway identifier (ID) and a pathway name.
Table 1 Number of pathway entries in different data
sources













*Numbers are based on ConsensusPathDB, accessed on 30/04/2013
Wu et al. BMC Systems Biology 2013, 7(Suppl 3):S2
http://www.biomedcentral.com/1752-0509/7/S3/S2
Page 2 of 9
Pathway IDs contains information about the source
database.
We note that there are some general names in the dic-
tionary, such as “Disease”, “Metabolism” and “Gene
Expression”. Those mentions mostly come from Reactome
and KEGG. We decided to keep all entries for complete-
ness and automated updates, although we note that they
are ambiguous and can be used to describe generic biolo-
gical concepts.
To better understand the composition of pathway
names, we have conducted a lexical profiling of six repre-
sentative databases (BioCarta, KEGG, PID, Reactome,
WikiPathways, Pathway Ontology). We analysed frequent
tokens and keywords and mentions of genes/proteins.
The analysis revealed some interesting (but expected) dif-
ferences between different pathway database sources (see
the Results section).
PathNER workflow
The workflow implementing PathNER is shown in Fig-
ure 1. PathNER applies soft dictionary matching and
rules. Pathway mentions identified by the two compo-
nents are consequently merged. PathNER is built upon
the open-source text engineering framework GATE
Embedded [23]. Documents are pre-processed (tokenisa-
tion, sentence splitting, Part-of-Speech (POS) tagging)
using the OpenNLP plugin.
Soft dictionary matching
To match pathway mentions in text, we employed soft
dictionary matching as term variations often cause exact
string matching to fail [24]. Typical term variations
include insertion/deletion of stop-words and word per-
mutations (often due to the use of prepositions, e.g.
“p53 signalling pathway” and “signalling pathway of
p53”), morphological variations (e.g. “transcriptional fac-
tor” and “transcription factor”) and using alternative
keywords (e.g. “MAPK pathway” and “MAPK signalling
pathway”).
The core of the soft dictionary matching method is
calculating the similarity between two given strings (one
as query, the other as pattern) using appropriate distance
metrics. PathNER utilises the SoftTFIDF method imple-
mented in the open-source Java toolkit SecondString
[25]. SoftTFIDF is a combination of the TFIDF weighting
scheme and the Jaro-Winkler string distance scheme, and
has been reported as one of the best performing among
multiple commonly seen string distance metrics [25]. The
SoftTFIDF dictionary lookup takes a dictionary and a
query string as input, and outputs a list of possible
matches ranked by their SoftTFIDF similarity score (a
float number between 0 and 1) against the query string.
A configurable threshold is used to filter low-scoring
matches.
To match against a whole document, a set of candi-
date query strings needs to be generated. We have
developed a tailored method where the first step for
candidate selection is to find possible starting points for
potential candidates. To that end, each token is first
sent to SoftTFIDF lookup configured with a relatively
low threshold (any match scores less than this threshold
will be discarded at this stage; the value of this threshold
(referred to as “the lower threshold”) is empirically set
as 0.40). If the result set is not empty, then the token’s
position is recorded as a potential starting point for a
possible match candidate. This prevents unnecessary
matching attempts starting from tokens that do not
appear in the dictionary. In the second step, we check
each recorded starting point with different lengths of
the window: each check starts with a window length of
one and the window length is increased until it reaches
the maximum (the longest entry in the dictionary has
20 tokens, but the maximum was set to be 25 to allow
potential insertion of stop-words). Tokens within the
window form a query string for SoftTFIDF that is also
configured with the lower threshold. If the result set is
not null, the check continues; if more than four (an
empirically determined value) consecutive window
lengths find no matches by SoftTFIDF lookup, the
check stops and a new check starts from the next possi-
ble position. During each check, the match results for
different window lengths are stored. The longest possi-
ble match which scores over a high threshold (empiri-
cally set as 0.90) are returned. Generally speaking, a
Figure 1 Workflow of PathNER. PathNER is built upon GATE framework and combines soft dictionary matching and rule-based detection.
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smaller value for the lower threshold slows down the
processing speed, whereas a larger value can decrease
recall; for the higher threshold, a greater value poten-
tially increases precision but reduces recall and a smaller
value increases recall but potentially hinder precision.
We note that these thresholds are configurable in
PathNER.
Rule-based recognition
The rule-based component aims to complement the soft
dictionary lookup method in particular to address name
variation and missing names. It works by integrating
three types of information: general pathway-specific key-
words, POS tags and gene/protein recognition results.
The component is implemented using the Java Annota-
tion Patterns Engine (JAPE) within the GATE framework.
The pathway-specific keywords we used include “path-
way”, “signalling” (and “signalling”), “transduction”, “cas-
cade” and “network”. Specific combinations of those
keywords are also considered as keywords (e.g., “signal-
ling pathway”, “signalling cascade”, “signalling network”,
etc.). Gene/protein mentions are recognised by BAN-
NER [4].
We developed two types of rules: backward and for-
ward. Backward rules start from a keyword found in the
text. PathNER then scans backwards for one of the fol-
lowing five types of tokens: determiners (e.g. “the”, “all”,
“such”, etc.), separators (e.g. comma, period, semicolon,
etc.), prepositions or subordinating conjunctions (e.g.
“about”, “in”, “because”, “after”, etc.), wh-words (e.g.
“when”, “whatever”, etc.) and verbs. These tokens indi-
cate potential starting points of a pathway mention. For-
ward rules scan forward from the pathway keyword
position for pathway-specific verb phrases (e.g. “induced
by”, “regulated by”, “mediated through”, etc.) until any
punctuation character is met.
Segments anchored by these rules are then integrated
with the results generated by BANNER. If BANNER
reports any mention of gene/protein-like names that are
contained within a rule-detected segment, then the seg-
ment is tagged as a named pathway mention.
Results merging
We generate the final annotation set by merging the
results from the above two components. Mentions
detected by only one component are added directly to
the final set. For overlapped annotations, a new annota-
tion covering both is generated and added to the final
set.
Evaluation Methodology
There is no gold-standard corpus that annotates path-
ways at the mention level. We used the GENIA corpus
[26] to generate a subset of abstracts with manually
annotated pathway mentions. The original GENIA cor-
pus contains 1,999 Medline abstracts, which were
retrieved from PubMed using three MeSH terms
“human”, “blood cells” and “transcription factors”. The
terms in the corpus have been manually annotated for
over 30 biological entity types including proteins, genes
and cells. Although pathways are not specifically
included in original GENIA annotations, we have noted
that many of pathway mentions have been annotated
with a generic label (G#other_name).
Our gold-standard corpus was derived from GENIA in
two parts, which are both manually annotated for men-
tions of named pathways. The first part is a collection
of 50 randomly sampled abstracts from the GENIA cor-
pus. As randomly selected articles might contain too
few pathway mentions for meaningful evaluation, we
engineered the second part to ensure that there are ade-
quate pathway mentions for evaluation. This part is
derived from the GENIA sentences that contain both a
G#other_name label and pathway-specific keywords.
These sentences were manually checked and only
named pathway mentions were labeled. As a result, the
annotated gold-standard corpus (available in Additional
file 2) contains 726 annotations of pathway mentions, of
which 448 are lexicographically unique. We note that
379 pathways appeared only once in the corpus.
To measure the performance of PathNER against the
gold-standard corpus, we adopted standard metrics: Pre-








, F1 = 2
P · R
P + R
where TP is the number of true positives, FP is the
number of false positives and FN is the number of false
negatives.
Application of PathNER on Alzheimer’s disease corpus
To illustrate the potential of PathNER for curators and
systems biologists who are interested in relationships
between pathways and diseases, we applied PathNER to
Alzheimer’s disease (AD). AD-related pathways have
been already manually curated within the AlzPathway
database [27]. The database contains 119 intra, inter and
extra cellular AD signalling pathways curated from over
100 review articles. The curation process followed a
two-step procedure: the first step determined what path-
ways are involved in AD, whereas the second step
retrieved molecular details for those selected pathways.
We aim to illustrate here how PathNER can be used to
support the first step.
To support the task, we constructed two corpora of AD-
related articles: Alz_ARF_PubMed and Alz_ARF_PMC
(see Table 2 and Additional file 3). Alz_ARF_PubMed
Wu et al. BMC Systems Biology 2013, 7(Suppl 3):S2
http://www.biomedcentral.com/1752-0509/7/S3/S2
Page 4 of 9
contains abstracts and comes from the recommendations
of the Alzheimer Research Forum (ARF) [28].
Alz_ARF_PMC contains available full-text articles of
abstracts from Alz_ARF_PubMed; only open-access arti-
cles were retained for text mining. Documents have been
downloaded using gnEutils4j [29]. After applying PathNER
on these corpora, we manually normalised pathway men-
tions to get unique mentions (for instance, “Wnt signalling
cascades”, “Wnt-signalling”, “wnt signal transduction path-




Table 3 shows lexical profiles (top 10 tokens) of six repre-
sentative databases (BioCarta, KEGG, PID, Reactome,
Wikipathways, Pathway Ontology). It is interesting that
the table highlights the different foci of the databases. For
instance, “metabolism” comes on top for KEGG, whereas
others databases contain more occurrences of “pathway”
and “signalling” keywords. The differences in lexical con-
stituents highlight the importance of compiling different
entries into the dictionary.
Table 4 shows the number of entries that contain gen-
eral pathway-specific keywords and gene/protein names
(as detected by BANNER). Seven out of twelve databases
analysed have more than half of their entries contained
mentions of genes/proteins and keywords. We note that
this percentage could be larger as BANNER failed to
recognise gene/protein names in several entries, as it
requires a wider context for processing than just a path-
way name string. It is therefore important that our rule-
based component takes gene/protein names and keywords
into account.
PathNER performance on gold corpus
We separately evaluated the performance of PathNER com-
ponents and the integrated system. The results for both
strict (requires exact matching between annotations by the
gold standard and annotations by PathNER) and lenient
matching (annotations by PathNER that overlap with
the gold standard are accepted) are presented in Table 5.
PathNER achieves a lenient F1-score of 84%. The combina-
tion of soft dictionary matching and rules considerably
improved the performance. For lenient evaluation, recall
improved from 58% (rule-based) and 63% (soft dictionary
matching) to 88% (hybrid), while keeping precision at an
acceptable level (81%). This is similar in strict evaluation:
recall improved from 51% (rule-based) and 44% (dictionary
matching) to 80% (hybrid), with precision at 74%. For com-
parison, a baseline method that used our dictionary and
dictionary matching typically used for NER (we used LIN-
NAEUS [7]) achieved notably lower values (F1-score of
38% and 54% for strict and lenient matching respectively).
PathNER results on the AD corpora
Table 6 lists the number of detected mentions in the AD
corpora. Each full-text article contains around ten pathway
mentions on average, among which around two are
unique. This is much higher than what can be found in
abstracts (less than 0.2 mentions per abstract), so the avail-
ability to process full-text articles is extremely important.
Table 7 and Table 8 further show the top 25 most fre-
quent pathway mentions detected in the AD corpora.
The different corpora exhibit quite good consistency (19
shared mentions in the top 25) but the differences again
highlight the need to process full texts. For instance, the
“Insulin/IGF-1 Signalling” detected from Alz_ARF_PMC
is not in the top 25 of Alz_ARF_PubMed but it is
indeed closely related to AD [30].
Table 2 Statistics of the AD corpora
Corpus Type # of articles # of open-access
Alz_ARF_PubMed Abstracts 1,983 ALL
Alz_ARF_PMC Full-texts 732 87
Table 3 Top 10 tokens from pathway names in representative databases
BioCarta KEGG PID Reactome WikiPathways PO
Rank Token Freq Token Freq Token Freq Token Freq Token Freq Token Freq
#1 pathway 6.09% metabolism 6.01% signalling 3.66% activation 1.68% signalling 5.38% pathway 23.34%
#2 signalling 4.63% pathway 3.63% pathway 2.56% signalling 1.63% pathway 4.55% signalling 9.52%
#3 regulation 1.79% signalling 3.50% activation 1.27% metabolism 1.18% metabolism 3.11% altered 3.02%
#4 cell 1.65% biosynthesis 3.25% events 1.23% synthesis 1.06% regulation 1.38% metabolic 2.88%
#5 role 1.06% cell 1.50% regulation 1.17% regulation 0.95% cell 1.31% mediated 1.69%
#6 receptor 1.06% acid 1.38% mediated 1.03% mediated 0.90% receptor 1.04% biosynthetic 1.39%
#7 activation 0.99% cancer 1.25% receptor 1.02% transport 0.86% activity 0.83% degradation 0.79%
#8 kinase 0.86% infection 1.00% cell 0.73% receptor 0.80% synthesis 0.83% drug 0.78%
#9 gene 0.73% disease 0.88% metabolism 0.64% complex 0.69% cycle 0.83% factor 0.78%
#10 cycle 0.66% degradation 0.75% synthesis 0.63% receptors 0.69% proteins 0.83% acid 0.72%
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It is interesting that only six and ten out of 25 top men-
tioned pathways in the respective abstract and full-text
corpora already appeared in the AlzPathway database. We
however note that AlzPathway focuses on signalling path-
ways, whereas PathNER also extracted a number of meta-
bolic pathways. Still, the Notch signalling, which was
identified by PathNER, does not appear in AlzPathway,
although it has been reported as important for under-
standing the pathogenesis and treating of AD [31]. To
further validate the results, we searched for literature
evidence for each non-curated pathway in the top 25 -
none of those was irrelevant to AD (see tables 7 and 8 for
relevant evidence publication).
There are, on the other hand, pathways present in
AlzPathway that were not detected by PathNER. One of
the likely reasons is that PathNER was applied on a lim-
ited set of articles (less than 2,000; PubMed returns
more than 5,400 abstracts related to AD that mention
any of the pathway-specific keywords).
Discussion
PathNER is based on soft dictionary matching and addi-
tional rules, which enables it to address term variations.
The performance improvement shows the complementarity
of the two approaches. The rules, in particular, proved to
be useful for spotting complex pathway mentions. For
example, “...activation of the ras/raf/MAPK kinase (MEK)/
ERK and phosphatidylinositol 3-kinase (PI-3K)/AKT/mam-
malian target of rapamycin (mTOR) signalling pathways“
[PMID: 19723757] can be captured by PathNER but it can
be very hard for any dictionary-based method. While the
rules were often successful, their coverage can still be
improved. For instance, PathNER was not able to recognise
a much simpler “microglial activation” (which is a pathway
listed in AlzPathway) as it did not contain any of our path-
way-specific keywords or gene/protein name. PathNER
would therefore need to be extended with other potential
clues. For example, Table 4 shows that the percentage of
gene/protein names is low in names of pathways appearing
in PharmGKB (mainly about drug pathways), SMPDB
(small molecule pathways), HumanCyc and EHMN (mostly
about metabolic pathways), and therefore other specific
keywords need to be identified. In addition, some false posi-
tives were due to missed gene/protein names, so integration
with other gene name recognition tools might be useful
(e.g. [32], [33]). Similarly, context-dependent identification
of acronyms and their expended forms would help in
detecting mentions such as “T cell receptor (TCR)
signalling”.
If recognised pathway mentions are to be linked to a
database entry, then rules will need to provide some
additional matching. For instance, although ‘the CD2
pathway’ has been mentioned in many articles related to
T lymphocytes, it was not an entry in our dictionary.
CD2 is the acronym for “Cluster of Differentiation 2”
and it represents a cell adhesion molecule. The closest
relevant entry we found was “Cell adhesion molecules
(CAMs)” [KEGG:hsa04514], but linking “the CD2 path-
way” to “Cell adhesion molecules (CAMs)” would
require significant background knowledge.
The AlzPathway case study was used to illustrate the
potential of PathNER in identifying relationships
between pathways and disease, using a relatively small
set of documents. Even within this restricted scenario,
we have shown how PathNER can help identity relevant
disease pathways, and thus facilitate the curation pro-
cess. It generated some new suggestions that were not
included in the human-curated AlzPathway database.
PathNER could provide a curation support by enabling
fast detection of pathway mentions based on a much
more comprehensive collection of articles than used in
AlzPathway (only 100 articles) or indeed in our case
study (around 2000 articles). The results are interesting
in two aspects: on one hand, PathNER could contribute
to prioritising pathways for curation (e.g. most frequent
ones; most recent or most cited) and thus help address
the limitations on time and resources available to carry
out the curation. On the other hand, the successful
Table 4 Numbers of dictionary entries with pathway













INOH 90 55 53 96.36%
NetPath 48 48 45 93.75%
PID 1329 433 280 64.67%
KEGG 273 39 22 56.41%
WikiPathways 376 129 72 55.81%
Reactome 1411 243 134 55.14%
BioCarta 260 117 64 54.70%
PO 1609 1556 512 32.90%
PharmGKB 96 92 17 18.48%
SMPDB 467 215 33 15.35%
HumanCyc 308 29 3 10.34%
EHMN 78 1 0 0.00%






Baseline 0.32 0.49 0.38 0.43 0.66 0.54
Soft
dictionary
0.44 0.51 0.47 0.63 0.72 0.67
Rules 0.51 0.86 0.64 0.58 0.97 0.72
PathNER 0.80 0.74 0.77 0.88 0.81 0.84
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application of PathNER on the AD corpora suggests that
PathNER can be used to guide the curation of pathway
maps related to other human diseases in a systematic
way (e.g. the diseases where there are no organised com-
munity curation efforts).
PathNER integrates dictionaries and rules, instead of
relying on machine learning which is another popular
NER approach. There are several reasons for that.
Machine-learning approaches require a fairly large
amount of annotated samples for training, which were
not available in this case. On the other hand, public
pathway databases with names are readily available and
patterns commonly used for mentioning pathways are
well understood. Therefore, an approach based on soft
dictionary matching and rules becomes a natural choice.
As a NER tool, PathNER aims to identify pathway
name mentions. On the other hand, text-mining systems
that aim to reconstruct pathways from literature aim to
identify constituent entities in the text and then perform
information extraction to identify the relationship
between those entities. Consequently, we cannot com-
pare PathNER with those systems as they are addressing
different problems. However, PathNER can serve as a
complementary/component tool in such systems as dif-
ferent entities (genes, proteins, small molecules, etc.)
can interact with pathways to build new pathways. By
tagging pathway mentions as a type of entity with Path-
NER, it would be possible to utilise existing interaction
extraction systems (e.g. [34]) to retrieve interactions that
involve named pathways that contribute to the patho-
genesis of certain diseases.
Table 6 Numbers of pathway mentions in the AD corpora
Corpus Processed articles Total mentions Unique mentions Mention per article Unique mention per article
Alz_ARF_PubMed 1,983 1,961 363 0.99 0.18
Alz_ARF_PMC 85 883 203 10.39 2.39
Table 7 Top 25 detected mentions in the
ALZ_ARF_PUBMED corpus
Detected Mention Freq In AlzPathway? Evidence
Alzheimer’s disease 1869 N/A N/A
Disease 1121 N/A N/A
Parkinson’s disease 201 NO PMID: 12672864
Amyotrophic lateral sclerosis 143 NO PMID: 1571856
Metabolism 123 N/A N/A
Apoptosis 120 YES PMID: 11227497
Oxidative stress 99 YES PMID: 10681270
Transcription 99 N/A N/A
Long-term potentiation 98 YES PMID: 12399581
Gene expression 94 YES N/A
Proteasome 67 NO PMID: 10854289
Huntington’s disease 59 NO PMID: 15686606
Cell cycle 56 YES PMID: 15936057
Methylation 35 NO PMID: 19606065
Translation 35 N/A N/A
Acetylation 33 YES PMID: 19625751
Endocytosis 27 NO PMID: 16442855
Notch signalling 21 NO PMID: 19853579
Glucose metabolism 18 NO PMID: 21971455
Obesity 17 NO PMID: 19801534
Long-term depression 16 NO PMID: 21854392
Signal transduction 15 N/A N/A
Glycolysis 14 NO PMID: 14718371
Prion diseases 14 NO PMID: 15190676
Creutzfeldt-Jakob disease 13 NO PMID: 7904883
*N/A: Not applicable; the last column shows a PMID that provides evidence
that a given mention is linked to AZ.
Table 8 Top 25 detected mentions in the ALZ_ARF_PMC
corpus
Detected Mention Freq In
AlzPathway?*
Evidence
Disease 635 N/A N/A
Alzheimer’s disease 174 N/A N/A
Amyotrophic lateral sclerosis 130 NO PMID: 1571856
Methylation 95 NO PMID: 19606065
Long-Term Potentiation 78 YES PMID: 12399581
Oxidative Stress 69 YES PMID: 10681270
Transcription 65 N/A N/A
Parkinson’s Disease 48 NO PMID: 12672864
Cell cycle 46 YES PMID: 15936057
Metabolism 44 N/A N/A
Axon guidance 32 YES PMID: 17571925
Gene expression 31 YES N/A
Glucose metabolism 23 NO PMID: 21971455
Calcium signalling 20 YES PMID: 21184278
Acetylation 18 YES YES
Apoptosis 16 YES PMID: 11227497
Activation of the Rac
signalling pathway
15 NO PMID: 10817927
Notch signalling 14 NO PMID: 19853579
Prion diseases 12 NO PMID: 15190676
Proteasome 12 NO PMID: 10854289
S phase 12 YES PMID: 19946466
Translation 12 N/A N/A
Endocytosis 10 NO PMID: 16442855
Insulin/IGF-1 Signalling 10 NO PMID: 22817723
Post-translational
modifications
9 YES PMID: 21215781
*N/A: Not applicable; the last column shows a PMID that provides evidence
that a given mention is linked to AZ.
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Conclusions
In this paper we presented PathNER, a tool that can sys-
tematically detect biological pathway mentions in litera-
ture with a lenient F1-score of 84%. In contrast to
existing text-mining efforts that target the automatic
reconstruction of pathway details from molecular interac-
tions mentioned in the literature, PathNER focuses on
identifying specific named pathway mentions. We also
demonstrated that PathNER could provide a curation
support by providing reliable curation suggestions from
most frequent pathway mentions in the primary literature
associated to a particular disease. Another potential audi-
ence of PathNER are systems biologists who want to
investigate the relationship between pathways and disease
or other biological entities. The future work will include
extending the rule component, in particular through
mapping of recognised mentions to most similar entries
in pathway databases. In addition, we aim to develop a
“pathway names crawler” that will crawl the literature for
new pathway names to update our dictionary.
Availability
PathNER together with the Alzheimer’s corpora as well
as the extracted results are available at http://source-
forge.net/projects/pathner/ under the Common Public
License 1.0.
Additional material
Additional file 1: Dictionary of pathway names. The dictionary is a .txt
file, with each line represents one dictionary entry. The data comes from
ConsensusPathDB and Pathway Ontology. (human data only).
Additional file 2: Gold corpus. The gold corpus is an .xml file. To open,
please download and install the freely available GATE developer program
[http://gate.ac.uk/]. After installation, open GATE, and create a new
‘Language Resources’ with the ‘GATE Document’ type, select the path of
this .xml file.
Additional file 3: AD corpora. The corpora are compressed in the .tar.
gz file. Once decompressed, you will get four separate .txt files. Each txt
file contains multiples lines of PubMed IDs or PubMed Central IDs, one
ID per line.
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POS: Part-Of-Speech; NER: Named Entity Recognition; AD: Alzheimer’s
disease; KEGG: Kyoto Encyclopaedia of Genes and Genomes; PID: Pathway
Interaction Database; PO: Pathway Ontology; JAPE: Java Annotation Pattern
Engine; PMID: PubMed ID.
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